Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...
In 2001, chemists K. Barry Sharpless, Hartmuth C. Kolb, and M. G. Finn introduced click chemistry, a concept in which organic ...
Optimally positioning CD19-directed therapies in the follicular lymphoma treatment sequence requires consideration of both ...
The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...
Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...
In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...
Morning Overview on MSN
New imaging breakthrough makes cancer cells light up on cue
Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical ...
In 2001, chemists K. Barry Sharpless, Hartmuth C. Kolb, and M. G. Finn introduced click chemistry, a concept in which organic molecules can be rapidly ...
Horsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT FASPRO ...
Detailed price information for Telo Genomics Corp (TELO-X) from The Globe and Mail including charting and trades.
Thymagen (also called thymogen; dipeptide Glu-Trp, EW) is a synthetic peptide analog derived from thymic extracts and regarded in peptide bioregulator research for its putative immunoregulatory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback